Luminex Corporation

Omeros Corporation is a leading biopharmaceutical company based in Seattle, WA. With a focus on innovative and cutting-edge science, their world-class team has achieved scientific breakthroughs that have led to the development of wholly new classes of therapeutics, benefiting patients with challenging diseases and disorders. Their deep and diverse pipeline of small-molecule and protein therapeutics includes first-in-class drugs with new mechanisms of action, targeting previously untapped receptors and enzymes. The Omeros team is known for being exceptionally talented, passionate, collaborative, and diverse. They are committed to hiring smart, creative, and hard-working individuals from around the world who want to make a meaningful impact in the biopharmaceutical industry. Together, they strive to provide hope to patients and their families by delivering better outcomes and life-saving therapies.Generated from the website

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website

Founded in 1987, Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides, the building blocks of DNA and RNA in the United States. The company discovers, develops and commercializes medications to advance the care of patients suffering from life-threatening diseases. Headquartered in Foster City, Calif., it serves North America, Europe and Australia and employs a staff of more than 3,400 individuals. Gilead Sciences areas of focus include antivirals, such as HIV/AIDS and chronic hepatitis, as well as cardiovascular conditions, including pulmonary arterial hypertension and resistant hypertension. The company also conducts studies on various respiratory diseases, such as influenza and cystic fibrosis.